2025 Nelson's Pediatric Antimicrobial Therapy (Paperback, 31, Thirty-First)

Introduction
Abbreviations
Notable Changes to 2025 Nelson’s Pediatric Antimicrobial Therapy, 31st Edition
Antimicrobial Therapy According to Clinical Syndromes
Antimicrobial Therapy for Neonates
Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens
Choosing Among Antibiotics Within a Class: B-Lactams and B-Lactamase Inhibitors, Macrolides, Aminoglycosides, and Fluoroquinolones
Preferred Therapy for Specific Fungal Pathogens
Choosing Among Antifungal Agents: Polyenes, Azoles, and Echinocandins
Preferred Therapy for Specific Viral Pathogens
Choosing Among Antiviral Agents
Preferred Therapy for Specific Parasitic Pathogens
Choosing Among Antiparasitic Agents: Antimalarial Drugs, Nitroimidazoles, Benzimidazoles, and Neglected Tropical Diseases
How Antibiotic Dosages Are Determined by Susceptibility Data, Pharmacodynamics, and Treatment Outcomes
Approach to Antibiotic Therapy for Drug-Resistant Gram-Negative Bacilli and Methicillin-Resistant Staphylococcus aureus
Antibiotic Therapy for Children With Obesity
Sequential Parenteral-Oral Antibiotic Therapy (Oral Step-Down Therapy) for Serious Infections
Antimicrobial Prophylaxis/Prevention of Symptomatic Infection
Approach to Antibiotic Allergies
Antibiotic Stewardship
Systemic and Topical Antimicrobial Dosing and Dose Forms
Appendix: Nomogram for Determining Body Surface Area
References
Index